Anthony Turpin

22PUBLICATIONS
129CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 24, 2026
Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

|Jul 13, 2026
A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

|Oct 06, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi).

Marine Valery, Julien Edeline, Julie Henriques

|Apr 04, 2025
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study).

Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse

|Jun 26, 2024
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology.

Elodie Martin, Karine Le Malicot, Catherine Guérin-Charbonnel

|Apr 08, 2024
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort.

Antoine Lebeaud, Leony Antoun, Jane-Rose Paccard

Pageof 4

Frequent Collaborators

5 joint publications

Julien Edeline

4 joint publications

David Malka

3 joint publications

Jean-Baptiste Bachet

2 joint publications

Mehdi El Amrani